Dr. Malini Patel

Claim this profile

Rutgers Cancer Institute of New Jersey

Studies Nasopharyngeal Carcinoma
Studies EBV Infection
2 reported clinical trials
6 drugs studied

Area of expertise

1Nasopharyngeal Carcinoma
Malini Patel has run 1 trial for Nasopharyngeal Carcinoma. Some of their research focus areas include:
Stage II
Stage III
Stage IV
2EBV Infection
Malini Patel has run 1 trial for EBV Infection. Some of their research focus areas include:
Stage II
Stage III
Stage IV

Affiliated Hospitals

Image of trial facility.
Rutgers Cancer Institute Of New Jersey
Image of trial facility.
Rutgers New Jersey Medical School

Clinical Trials Malini Patel is currently running

Image of trial facility.

Pembrolizumab

for Early-Stage Non-Small Cell Lung Cancer

A randomized trial of adjuvant Pembrolizumab following surgical resection versus observation following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm. Patients will be randomized (1:1) 4-12 weeks following surgery to either: * Arm A: Pembrolizumab 400 mg every 6 weeks × 9 cycles * Arm B: Observation Stratification factors will include: PD-L1 TPS (\<50% vs. ≥50%), and tumor size (1-2 cm vs. \>2-4 cm)
Recruiting1 award Phase 25 criteria

More about Malini Patel

Clinical Trial Related10 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Malini Patel has experience with
  • Cisplatin
  • Fluorouracil
  • Gemcitabine Hydrochloride
  • Intensity-Modulated Radiation Therapy
  • Paclitaxel
  • Pembrolizumab
Breakdown of trials Malini Patel has run
Nasopharyngeal Carcinoma
EBV Infection
Cancer
Nasopharyngeal Cancer
Non-Small Cell Lung Cancer

Other Doctors you might be interested in

Shridar GanesanRutgers Cancer Institute of New Jersey
OBI Investigator SiteUniversity of Texas Health Science Center at San Antonio
Adam BergerRutgers Cancer Institute of New Jersey

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Malini Patel specialize in?
Malini Patel focuses on Nasopharyngeal Carcinoma and EBV Infection. In particular, much of their work with Nasopharyngeal Carcinoma has involved Stage II patients, or patients who are Stage III.
Is Malini Patel currently recruiting for clinical trials?
Yes, Malini Patel is currently recruiting for 1 clinical trial in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Malini Patel has studied deeply?
Yes, Malini Patel has studied treatments such as Cisplatin, Fluorouracil, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Malini Patel?
Apply for one of the trials that Malini Patel is conducting.
What is the office address of Malini Patel?
The office of Malini Patel is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top